Editorial: should we abandon HCV genotype testing? Maybe

Abstract

1. Yu D, Ramsey FV, Norton WF, et al. The burdens, concerns, and quality of life of patients with gastroparesis. Dig Dis Sci. 2017;62:829‐ 893. 2. Eisen GM, Locke GR, Provenzale D. Health‐related quality of life: a primer for gastroenterologists. Am J Gastroenterol. 1999;94:2017‐ 2021. 3. Navas CM, Crowell MD, Lacy BE. The willingness of patients with gastroparesis to take risks with medications. Aliment Pharmacol Ther 2019;49:429‐436. 4. Von Neumann J, Morgenstern D. The theory of games and economic behavior, 3rd ed. New York, NY: John Wiley; 1953. 5. Lacy BE, Yu J, Crowell MD. Medication risk‐taking behavior in functional dyspepsia patients. Clin Transl Gastroenterol. 2015;6:e69. 6. Teigland T, Iversen MM, Sangnes DA, Dimcevski G, Softeland E. A longitudinal study on patients with diabetes and symptoms of gastroparesis—associations with impaired quality of life and increased depressive and anxiety symptoms. J Diabetes Complications. 2018;32:89‐94. 7. Lacy BE, Everhart KK, Weiser KT, et al. IBS patients’ willingness to take risks with medications. Am J Gastroenterol. 2012;107:804‐809. 8. Kaplan RM, Feeny D, Revicki DA. Methods for assessing relative importance in preference based outcome measures. Qual Life Res. 1993;2:467‐475. 9. Slovic P. Perception of risk. Science. 1987;236:280‐285. 10. Lenert LA, Cher DJ, Goldstein MK, Bergen MR, Garber A. The effect of search procedures on utility elicitations. Med Decis Making. 1998;18:76‐83.